SE
Therapeutic Areas
Carvolix Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TAVIPILOT Soft | Guidance for Transcatheter Aortic Valve Implantation (TAVI) | Approved/Commercial |
| TAVIPILOT Robot | Robotic assistance for Transcatheter Aortic Valve Implantation (TAVI) | Clinical Trials |
| Robotic Platform for Mechanical Thrombectomy | Treatment of Ischemic Stroke | Development |
| Epygon Biomimetic Mitral Valve | Treatment of Mitral Regurgitation | Clinical Evaluation |
| Robotically Delivered Mitral Valve | Treatment of Mitral Regurgitation | Research & Development |
| Artus Medical Device | Not specified (Legacy product) | Clinical/Regulatory |
Leadership Team at Carvolix
SL
Sébastien Ladet, Ph.D.
Chief Executive Officer
CD
Christophe de Vregille
Chief Financial Officer
JH
Jorgen Hansen
Chief AI & Robotics
CB
Céline Buard
Head of marketing and EU Commercialization
PH
Professor Howard Herrmann, MD
Chief Medical Officer
BR
Benjamin Renault, PhD
Chief Development Officer Implants and Instruments
PB
Pierre Berthet-Rayne, PhD
Chief Technology Officer Robotics
LT
Liane Teplitsky
Executive Chair of the Board of Directors
PP
Philippe Pouletty, M.D.
CEO of Truffle Capital, Founder of Carvolix
AC
Alain Chevallier
Senior Partner Truffle Capital